End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | AbbVie : Merck says hepatitis C drugs to lose breakthrough status | RE |
2014 | Apple : Wall St. edges up, lifted by mergers, acquisitions | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Teresa Dahlman
IRC | Investor Relations Contact | - | - |
Michele Liuzzi
PRN | Corporate Officer/Principal | - | - |
Adel Moussa
PRN | Corporate Officer/Principal | - | 02-02-28 |
John Mao
PRN | Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 151,503,782 | 117,733,252 ( 77.71 %) | 0 | 77.71 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- Stock
- Company Idenix Pharmaceuticals Inc